Hopp til innhold
NHI.no
Annonse

Bakteriell vaginose: Prognose

Innhold i artikkelen

Prognosen er god, det vil si at dette er en ufarlig tilstand. Tilbakefall er svært vanlig både hos de som er behandlet og hos de som er blitt bra av seg selv. Men heller ikke ved tilbakefall er det nødvendig med behandling dersom plagene er til å holde ut. Man blir ofte bra uten behandling, og det anses fornuftig å avvente utviklingen dersom plagene ikke er for uttalte. Når plagene er for uttalte, for eksempel på grunn av lukt, kløe eller ubehag, gis en kur. Behandlingen har som regel svært rask virkning, men gjentatte kurer kan bli nødvendig. 

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Bakteriell vaginose . Referanselisten for dette dokumentet vises nedenfor

  1. Romøren M, Juvkam KH, Moi H. Bakteriell vaginose. Lindbæk M (red). Nasjonale faglige retningslinjer for antibiotikabruk i primærhelsetjenesten. Oslo: Helsedirektoratet, sist oppdatert 12.2016.
  2. Allsworth JE, Peipert JF. Prevalence of bacterial vaginosis: 2001-2004 National Health and Nutrition Examination Survey data. Obstet Gynecol 2007; 109: 114. PubMed
  3. Kairys N, Garg M. Bacterial Vaginosis. 2020 Jul 10. In: StatPearls Internet. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. PMID: 29083654.
  4. Yen S, Shafer MA, Moncada J, et al. Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military. Obstet Gynecol 2003; 102: 927. PubMed
  5. Paavonen J, Brunham RC. Bacterial Vaginosis and Desquamative Inflammatory Vaginitis. N Engl J Med 2018; 379: 2246-54. doi:10.1056/NEJMra1808418 DOI
  6. Vodstrcil LA, Hocking JS, Law M, et al. Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis. PLoS One. 2013;8 :e73055. doi: 10.1371/journal.pone.0073055. eCollection 2013.
  7. Peebles K, Velloza J, Balkus JE et al. High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis. Sex Transm Dis. 2019 May;46(5):304-311. PMID: 30624309.
  8. Marrazzo JM, Antonio M, Agnew K, Hillier SL. Distribution of genital Lactobacillus strains shared by female sex partners. J Infect Dis 2009; 199: 680. PubMed
  9. Deese J, Pradhan S, Goetz H, Morrison C. Contraceptive use and the risk of sexually transmitted infection: systematic review and current perspectives. Open Access J Contracept. 2018 Nov 12;9:91-112. PMID: 30519127 PubMed
  10. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983; 74:14-22. PubMed
  11. Lowe NK, Neal JL, Ryan-Wenger NA. Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe laboratory standard. Obstet Gynecol 2009; 113: 89-95. PubMed
  12. Nodenes K, Gammelsrud KW, Findal-Drammen G. Bakteriell vaginose. Veielder i fødselshjelp. Norsk gynekologisk forening. Oslo, 2020 www.legeforeningen.no
  13. Brocklehurst P, Gordon A, Heatley E, Milan SJ. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database of Systematic Reviews 2013, Issue 1. Art. No.: CD000262. DOI: 10.1002/14651858.CD000262.pub4. DOI
  14. Amaya-Guio J, Viveros-Carreño DA, Sierra-Barrios EM, Martinez-Velasquez MY, Grillo-Ardila CF. Antibiotic treatment for the sexual partners of women with bacterial vaginosis. Cochrane Database of Systematic Reviews 2016, Issue 10. Art. No.: CD011701. DOI: 10.1002/14651858.CD011701.pub2 DOI
  15. Mendling W, Weissenbacher ER, Gerber S, et al. Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review. Arch Gynecol Obstet 2016; 293: 469-84. pmid:26506926 PubMed
  16. Myrhaug HT, Brurberg KG, Kirkehei I og Reinar LM. Klindamycin til gravide med asymptomatisk bakteriell vaginose . Rapport fra Kunnskapssenteret nr 11 - 2010.
  17. Subtil D, Brabant G, Tilloy E et al. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial. Lancet 2018. pmid:30322724 PubMed
  18. Senok AC, Verstraelen H, Temmerman M, Botta GA. Probiotics for the treatment of bacterial vaginosis. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD006289. DOI: 10.1002/14651858.CD006289.pub2 DOI
  19. Huang H, Song L, Zhao W. Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials. Arch Gynecol Obstet. 2014 ;289(6):1225-34. doi: 10.1007/s00404-013-3117-0.
  20. Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S. Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 2008; 8: 3. PubMed
  21. Bradshaw CS, Morton AN, Hocking J, et al. High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence. J Infect Dis 2006; 193: 1478. PubMed
Annonse
Annonse